SAP’s Plattner aims to remove the bugs from the human machine

Last updated: October 28, 2013 4:30 pm

SAP’s Plattner aims to remove the bugs from the human machine

By Chris Bryant in Potsdam

More than 40 years after he transformed the business software market by co-foundingSAP, Hasso Plattner has set his sights on an even more daunting challenge: prolonging human life. At an age when many of his peers are playing leisurely rounds of golf, SAP’s chairman, who turns 70 next year, is pressing the company to broaden its focus beyond helping businesses to run more efficiently, by helping human beings to run more efficiently as well.The key, he explains, is enabling doctors and researchers to tap vast and various forms of medical data, help them perform lightning-quick calculations and analysis and thereby deliver personalised medical care.

If diseases are identified earlier, humans should live longer and the trend of rising healthcare costs could be reversed, so the theory goes.

“The data in this area are gigantic. A human genome has 3.2bn characters. Dealing with this puts an [ordinary] computer under stress,” he says.

His belief that the healthcare sector lies on the cusp of abig data revolution is not unique. According to McKinsey, the consultancy, over 200 businesses created since 2010 are building tools to make use of healthcare information.

Google last month launched a heathcare company called Calico that will attack some of the most difficult scientific problems in diseases related to ageing, whileIBM is developing data analysis technology to improve the treatment of traumatic brain injury among a range of activities in the healthcare sector.

Mr Plattner, however, claims that the difference in his approach is “Hana”, a high-speed database tool that he began developing with a team of PhD and Masters students seven years ago at his eponymous computer science institute in Potsdam.

“Hasso’s New Architecture” can run some complex studies in a matter of seconds, instead of hours or days, because it compresses the data and holds it in memory chips rather than on a separate disk. “The idea is that all requests are infinitely fast,” Mr Plattner says.

A researcher could therefore use Hana to conduct real-time genetic analysis, he says. By identifying an individual’s genetic variants and cross referencing these with a databank of other genomes, researchers could reveal which variants are a marker of susceptibility to particular illnesses, such as diabetes.

SAP has reworked its traditional business software applications so they can run on Hana and has signed up 2,100 corporate customers. Hana sales reached €149m in the third quarter.

However, its potential medical uses remain largely in the research phase. SAP has partnered with a variety of healthcare entities, including the Stanford School of Medicine, publishing house Springer Science and the Charité university hospital in Berlin to build potential applications.

Mr Plattner stresses that SAP does not want to compete with healthcare providers but to provide the platform on which they can run applications tailored to their needs.

Applying ‘big data’ analytics to healthcare

SAP chairman Hasso Plattner’s team has built a prototype healthcare software that allows a doctor to pull together and analyse huge volumes of data, ranging from medical records to clinical trial results and scientific journals. Wearable medical electronics that monitor a patient’s vital signs could also provide an additional new data stream for the platform.

By filtering data and identifying correlational relationships, doctors could establish in a matter of seconds the likelihood that a patient will respond to a particular drug treatment.

Mr Plattner says that, his database tool, called Hana, can integrate various kinds of biological, clinical and lifestyle data, similar to the way Google codifies the worldwide web. Currently these medical data are dispersed around the world in various formats – some structured, others unstructured – and are therefore hard to knit together.

Still, the SAP chairman’s passion for the subject – his father was a doctor – could help the German software company claim a slice of the healthcare analytics market, which is projected to grow to $10.8bn by 2017 from $3.7bn in 2012, according to ASDReports, a market research group.

Mr Plattner, who remains far more hands-on than is typical of German supervisory board chairman, argues that China’s vast population should mean it is a likely early adopter of big data analytics in healthcare.

“The new president of China came to Germany and spoke to one of our board members for half an hour about Hana, It’s unbelievable. None of our politicians here [in Germany] have ever asked me about Hana, and they won’t,” Mr Plattner says, displaying a famed propensity for impatience and tetchiness.

He acknowledges that not everyone is comfortable with the healthcare industry collecting and exploiting their personal data but draws a comparison here with the early age of automobiles.

“The protection of an individual must be ensured as much as possible but not at the price that we don’t do things that we could,” he says.

“Before there were cars there were also no traffic laws . . . It’s a similar thing here. We must make laws that regulate what happens with digital information.”

About bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: